Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

394
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
394
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.8K
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

452
In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
452
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

299
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
299

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genotype-Phenotype Heterogeneity Among Patients with Lipodystrophy Harboring Rare POLD1 Variants.

The Journal of clinical endocrinology and metabolism·2026
Same author

Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer.

International journal of molecular sciences·2026
Same author

Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance.

The Journal of clinical endocrinology and metabolism·2026
Same author

Type B Insulin Resistance: A Case Report of a Rare Complication of Systemic Lupus Erythematosus.

The Journal of rheumatology·2025
Same author

Serum Proteomics of Insulin Resistance Disorders Distinguish MASLD From Lipodystrophy and Insulin Receptor Defects.

The Journal of clinical endocrinology and metabolism·2025
Same author

Oral Glucagon-Like Peptide 1 Analog as an Adjuvant Therapy in Generalized Lipodystrophy.

Diabetes care·2025
Same journal

Letter to the Editor from DandinoÄŸlu: "Aggressive macroprolactinoma refractory to multiple lines of localized and systemic therapy".

JCEM case reports·2026
Same journal

Adrenal insufficiency after long-term high-dose ethinylestradiol use in a transgender woman.

JCEM case reports·2026
Same journal

Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1.

JCEM case reports·2026
Same journal

Triple islet autoantibody-positive type 1 diabetes in Japanese stiff-person syndrome despite a protective HLA haplotype.

JCEM case reports·2026
Same journal

Delayed diagnosis of juvenile hemochromatosis due to missed ferritin testing in a case of hypogonadotropic hypogonadism.

JCEM case reports·2026
Same journal

Nonclassic congenital adrenal hyperplasia and bilateral pheochromocytomas in a patient with a germline pathogenic <i>MAX</i> variant.

JCEM case reports·2026
See all related articles

Related Experiment Video

Updated: Jul 26, 2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

134

A Visual Diagnosis: Lipodystrophy.

Salman Zahoor Bhat1, Rebecca J Brown2, Ronadip R Banerjee3

  • 1Division of Endocrinology, Diabetes, and Metabolism, John Hopkins School of Medicine, Baltimore, MD 21287, USA.

JCEM Case Reports
|June 14, 2023
PubMed
Summary
This summary is machine-generated.

Partial lipodystrophy, a rare metabolic disorder, is often missed due to variable presentation. Early diagnosis through physical exams is crucial for effective treatment, including potential GLP-1 analog therapies.

Keywords:
GLP-1 analogsadipose tissuediabetesinsulin resistancelipodystrophyphysical exam

More Related Videos

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

6.9K
Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy
07:24

Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy

Published on: September 29, 2017

7.5K

Related Experiment Videos

Last Updated: Jul 26, 2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

134
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

6.9K
Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy
07:24

Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy

Published on: September 29, 2017

7.5K

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Rare Diseases

Background:

  • Lipodystrophy syndromes involve adipose tissue loss, leading to insulin resistance and dyslipidemia.
  • Partial lipodystrophy presents variably and is frequently misdiagnosed due to low physician awareness and inadequate physical examination.
  • Accurate diagnosis is essential for appropriate patient management and treatment strategies.

Observation:

  • The clinical features of partial lipodystrophy can be subtle, often overlooked in routine assessments.
  • A comprehensive physical examination is critical for identifying characteristic signs of lipodystrophy.
  • Physician awareness regarding the diverse presentations of lipodystrophy needs enhancement, especially in non-specialist settings.

Findings:

  • This review highlights the diagnostic challenges and clinical presentation of partial lipodystrophy.
  • The potential therapeutic role of Glucagon-like peptide-1 (GLP-1) analogs in managing lipodystrophy-associated metabolic complications is explored.
  • A clinical case illustrates the application of GLP-1-based therapy for glycemic control in lipodystrophy.

Implications:

  • Increased awareness and emphasis on physical examination can improve early diagnosis of partial lipodystrophy.
  • GLP-1 analogs represent a promising avenue for precision medicine in treating lipodystrophy syndromes.
  • This work aims to equip generalists and endocrinologists with knowledge for better patient care regarding lipodystrophy.